Disbursements reported by

REGENERON PHARMACEUTICALS, INC. PAC

Committee distributions reconstructed from FEC 15E recipient-side and 24T intermediary-side routed-contribution records, followed by operating expenses in a separate section.

Identified noncash accounting offsets are excluded before sorting and pagination. View asset disclosures and original accounting entries →